Alternatives to Curi

Efficiently address tissue heterogeneity and the intricacies of microenvironments using the GeoMx Digital Spatial Profiler (DSP), which stands out as the most versatile and powerful spatial multi-omic platform for examining both FFPE and fresh frozen tissue sections. Unique among spatial biology platforms, GeoMx allows for non-destructive profiling of RNA and protein expression across various tissue compartments and cell populations, supported by an automated and scalable workflow that seamlessly integrates with conventional histology staining. You can spatially profile the entire transcriptome along with over 570 protein targets, either separately or concurrently, utilizing sample inputs such as whole tissue sections, tissue microarrays (TMAs), or organoids. By choosing GeoMx DSP, you position yourself at the forefront of spatial biology for effective biomarker discovery and hypothesis validation. With the ability to determine the relevant boundaries, you can rely on biology-driven profiling that enables you to focus on the tissue microenvironments and cell types that hold the most significance for your research. This innovative approach ensures that your analyses are both comprehensive and tailored to the specific biological contexts of interest.

Monitor, assess, and minimize emissions from freight transport while ensuring comprehensive global visibility. Enhanced operations lead to timely deliveries, better inventory control, and an improved customer experience. Be prepared for future disruptions in the supply chain with increased resilience. The project44 platform offers in-depth visibility, a complete shipment lifecycle, and automation of workflows. Our data-driven strategy provides the necessary insights to alleviate supply chain risks and empower real-time decision-making through dynamic estimated times of arrival (ETAs), automated detection of exceptions, and proactive notifications. Our extensive network serves as the essential link for achieving the highest level of order-specific transportation visibility in the industry. The project44 platform accommodates a wider range of carriers, forwarders, shippers, and other supply chain stakeholders than any competing service, thereby ensuring comprehensive coverage and support. This unique capability positions project44 as a leader in the freight transportation sector.

Assess functional limitations and soft tissue damage effectively. Attract new clientele by creating initial benchmarks. Safeguard your practice from expensive Post Payment Review Audits. Validate medical necessity to secure more approvals for patients. Enhance patient loyalty and satisfaction levels. Thoroughly document any limitations or impairments and illustrate progress over time utilizing our widely-used software and hardware solutions. Each of our systems is customizable, with options to acquire devices individually or as part of a comprehensive package. As a healthcare provider, you understand that precise range of motion and muscle assessments are essential for crafting an effective treatment strategy. Proof Preferred enables you to measure and record your patient's range of motion and muscle strength quickly and accurately. This allows you to set patient baselines with ease and effectively assess functional impairments and soft tissue injuries. Additionally, you can offer more treatment options to your patients or help them reach their pre-injury condition or optimal medical improvement. By leveraging our technology, you can significantly enhance the quality of care provided to your patients.

Over the past twenty years, collaboration with innovative thinkers has enabled the identification, understanding, and reduction of errors from biopsy to data, resulting in significant advancements in tissue data mining tools, precision, workflow, and automation. Explore the realm of image analysis and tissue mining in both multi and highplexed images, where you can extract clinically significant patterns that provide insights into diseases, transforming your research tissue images into valuable knowledge. Discover the capabilities of CE-IVD APPs and workflows in image analysis, and redefine the approach to standardization through AI-powered pathology solutions that enhance diagnostic decision-making. The app center serves as your entry point to an extensive library filled with AI-driven applications, including those designed to adapt to your specific requirements. Additionally, you can peruse our collection of publications, guides, webinars, and posters to deepen your understanding of digital pathology and see how our software continually supports our clients in their research efforts. Embrace the future of pathology by leveraging these innovative tools and resources to elevate your work and contribute to advancing medical science.

The Sentinel system incorporates the sample container and cassette to capture an image of both the tissue and the label on the container. It continuously monitors the usage of containers and cassettes to prevent any potential mix-ups of specimens. During the transfer of tissue into the cassette, the Sentinel efficiently identifies, measures, and photographs each tissue piece. A gross report is automatically generated using the laboratory's specific template, which the technician reviews and subsequently adds to the patient’s records. In less than a second, the Sentinel precisely locates, measures, and images the tissue as it is placed into the cassette. Its measurements are notably more accurate and reliable compared to those taken manually by technicians. Additionally, the system produces visually appealing, full-color reports that include a gross description, details of the patient and clinician, as well as images of the container, its label, and the cassette itself, ensuring comprehensive documentation of the specimens. This advanced technology enhances the overall efficiency and accuracy of the specimen handling process.

CSAM ProSang is a sophisticated Laboratory Information Management System (LIMS) designed to streamline the complete process of overseeing blood, cells, and tissues from the point of donation to their eventual use in transfusions or transplants. Currently, it operates in five countries, serving over 180 blood centers distributed across 26 healthcare regions. The extensive features of CSAM ProSang encompass every element of blood donor management, as well as the administration, production, analysis, allocation, and delivery of blood for transfusion purposes. Additionally, it employs a consistent methodology applicable to stem cell, organ transplant, and tissue management processes. The system further manages immunological tests, which include assessments of immunogenicity and tissue-type serology. From the moment a donor's sample is collected, through all stages of production, analysis, and final delivery to the recipient, CSAM ProSang meticulously tracks each step using barcode labels. Its cutting-edge barcode technology not only enhances efficiency but also provides automatic alerts to users if an incorrect blood, cell, or tissue sample is detected, ensuring safety and accuracy throughout the process. This commitment to precision makes CSAM ProSang an essential tool in modern healthcare management.

Tempus AI, a prominent health technology firm based in Chicago, Illinois, is dedicated to transforming patient care through advanced artificial intelligence and precision medicine. By utilizing data and AI, the company strives to create personalized treatment plans across a range of medical specialties, such as oncology, cardiology, radiology, and mental health. Their all-encompassing platform combines genomic sequencing, clinical data, and AI-powered analytics, equipping healthcare providers and researchers with actionable insights. Tempus offers a holistic understanding of patients via various testing methods, including tissue and liquid biopsies, DNA and RNA sequencing, somatic and germline tests, as well as tumor-normal matched profiling and minimal residual disease monitoring options. Additionally, they provide a swift and dependable platform for ordering tests, gaining patient insights, and seamlessly integrating AI-driven technologies into practice. Furthermore, Tempus features an innovative generative AI-enabled clinical assistant that places patient insights readily at your fingertips, enhancing the overall efficiency of healthcare delivery. This commitment to leveraging cutting-edge technology exemplifies Tempus AI's mission to improve health outcomes and advance medical research.

Our innovative platform transforms the way patient measurements, analyses, and treatments are conducted. By utilizing Tissue Analytics, you can achieve a measurement error of less than 4%, a significant improvement over the 44% error associated with traditional ruler methods. This technology can streamline documentation processes, saving clinicians between 5 to 10 minutes for each patient, which can accumulate to at least 2.5 hours of saved charting time each day. Tissue Analytics automates the measurement of wound sizes and effortlessly uploads both images and measurements directly into the electronic medical record (EMR). This results in a comprehensive longitudinal record and detailed tissue composition data, enabling healthcare professionals to make more informed treatment choices. Clinicians will experience enhanced workflows, and we assure that nurses, clinicians, and administrators alike will observe improved outcomes. Moreover, existing EMR workflows often fall short of the needs of busy healthcare providers, but Tissue Analytics effectively addresses these inefficiencies, allowing for more patient interaction. Not only does our wound management platform enhance efficiency while saving your practice valuable time and resources, but it also integrates seamlessly with all major EMR systems, ensuring a smooth transition and enhanced functionality. Ultimately, adopting Tissue Analytics means empowering healthcare professionals to focus more on patient care rather than administrative burdens.

Ziva VFX is revolutionizing the creation of 3D characters for films, video games, and interactive media. By providing an intuitive set of tools, artists can easily mimic realistic physics and simulate various soft-tissue materials such as muscles, fat, and skin, resulting in assets that are of blockbuster caliber. The platform allows for the simulation of soft tissue materiality through user-friendly parameters and real-world measurements, all specifically designed for creature design. One of the standout features is the Ziva Anatomy Transfer tools, which enable users to quickly replicate, warp, and retarget creatures, facilitating the adaptation and multiplication of existing designs into countless high-quality characters. Additionally, modifications to character anatomy can be made retroactively, enabling creators to swiftly respond to changes and last-minute adjustments. Users can employ a range of material types, ensuring dynamic motion even with significant deformations, including StVK, NeoHookean, co-rotational, and anisotropic materials, enhancing the overall realism of their projects. This innovative approach not only streamlines the character creation process but also opens up new possibilities for storytelling in visual media.

At PathAI, we are dedicated to enhancing patient outcomes through trustworthy AI-driven technology and meaningful partnerships, with the goal of delivering the most precise diagnoses and effective treatments to patients. Our innovative translational platform, supported by our skilled team of scientists, biostatisticians, and machine learning experts, uncovers and examines new cellular and tissue patterns to identify pathology-related features that yield groundbreaking insights throughout all stages of drug development and various therapeutic domains. By employing dependable and consistent technology, our platforms aim to reduce observer variability and enhance patient selection and stratification, ensuring that the most suitable patients are included in each trial, thereby boosting the likelihood of successful outcomes. Additionally, our technology establishes the most accurate cut points, allowing us to enhance precision and maximize the number of patients who test positive for biomarkers, ultimately contributing to more effective treatments. This commitment to excellence positions us at the forefront of transforming healthcare through advanced analytics and collaboration.

Omda ProSang is a sophisticated Laboratory Information Management System (LIMS) designed for comprehensive management of blood, cells, and tissues, ensuring complete traceability from the donor to the recipient. This system is employed in various settings, including blood donation centers, immunohematology and clinical immunology laboratories, transplantation facilities, tissue establishments, and stem cell centers. With decades of reliable support for ISBT 128, Omda ProSang is a trusted solution for over 180 blood centers across five nations. It delivers a thoroughly documented process along with full traceability, which enhances oversight of the entire donor-to-recipient journey. The automation of processes significantly streamlines testing and analysis workflows while facilitating effective communication with donors. Additionally, the platform is equipped with robust safety mechanisms aimed at enhancing patient safety, and it features comprehensive statistics and analytical tools that empower healthcare providers to optimize their resource utilization. Overall, Omda ProSang stands out as an essential tool in modern transfusion medicine.

TrackCore's software streamlines tissue tracking procedures, enhancing operational efficiency so that your team can prioritize patient care effectively. With three distinct modules, it allows for compliant tracking of all biologic tissues and implantable medical devices, ensuring adherence to bi-directional traceability requirements. Additionally, it automates the bill-only process for hospitals and vendors regarding physician preference and special-order implants. We understand the critical importance of patient safety, and TrackCore is committed to surpassing all standards set by the FDA, the Joint Commission, and other accrediting organizations for your facility. Originally established as LPIT Solutions, Inc., TrackCore, Inc. is a vibrant and expanding entity dedicated to enhancing patient safety related to tissues and implants. Today, TrackCore's innovative solutions are utilized in over 700 hospitals across the country, reflecting its growth and commitment to excellence. Furthermore, TrackCore, Inc. continuously invests in the evolution of its product lineup to meet the ever-changing needs of healthcare providers.

Paige's offerings have the potential to revolutionize the practice of pathologists by instilling greater certainty in diagnoses. The company is committed to pioneering a new era of clinical tools and predictive assessments that empower pathologists while redefining the field of oncology. With its innovative AI solutions, Paige paves the way for the future of pathology. The Paige Platform serves as a comprehensive, secure solution that ensures interoperability with laboratory information systems (LIS), integrates multiple scanners, offers cloud storage, facilitates case management, enables image review through FullFocus®, and incorporates advanced AI applications. The Paige Prostate suite of AI tools is specifically designed to aid pathologists in identifying suspicious areas, grading and quantifying tissue samples, and assessing perineural invasion (PNI) in prostate needle core biopsies. Similarly, the Paige Breast suite of AI applications supports pathologists in evaluating breast cancer by enabling the identification of malignancies in breast biopsies and the detection of metastases in lymph nodes associated with breast tissue. Collectively, these advancements not only enhance diagnostic accuracy but also improve patient outcomes in oncology.

Create personalized tissue paper and much more with noissue. This platform empowers you to craft your own branded tissue paper and have it delivered globally within three weeks. You can either upload your logo and customize your design instantly or submit a template featuring your artwork. noissue was established to offer makers, brands, and businesses, regardless of their size, the opportunity to use custom, eco-friendly packaging solutions. The unique aspect of noissue lies in its dedication to sustainability across all products, coupled with an easy-to-use online design tool and low minimum order requirements. Become a part of our community and take the first step toward making a positive impact today! Additionally, by choosing noissue, you contribute to a greener future while enhancing your brand's identity with sustainable practices.

Accelerating the speed, precision, and affordability of cancer diagnoses is crucial, especially considering that one in three individuals will face this disease in their lifetime. Unfortunately, the current diagnostic process is often hindered by slow and costly methods, primarily due to the lack of advanced automated tools that support healthcare professionals. Qritive addresses this challenge by offering an AI-driven solution designed to assist physicians in analyzing both microscopy images and textual patient data efficiently. This innovation not only enhances the effectiveness of hospitals in diagnosing cancer but also contributes to significant cost savings. Additionally, Pantheon serves as a CE-marked, vendor-agnostic digital pathology platform that facilitates the complete digitization of pathology lab workflows and telepathology. It also supports comprehensive report generation and offers a robust platform for AI-driven analysis of whole-slide images in pathology. This technology is particularly adept at distinguishing between a variety of benign conditions and malignant diseases within breast tissue, which is vital for timely and accurate treatment. In doing so, it plays a pivotal role in transforming the landscape of cancer diagnostics.

WRDensity supports radiologists in evaluating breast density, promoting consistency in density assessments across their practices. Its primary aim is to facilitate early detection while ensuring patients feel reassured through enhanced consistency, confidence, and overall quality of care. Developed using advanced deep learning techniques, WRDensity analyzed over 600,000 images sourced from the esteemed Mallinckrodt Institute of Radiology, known for its pioneering work in the field. This robust deep learning model excels in providing precise classifications of breast density. Additionally, the batching and sorting features can boost user productivity by as much as 20%. By integrating WRDensity into the radiologist's existing workstation, critical information regarding tissue density is readily accessible in a relevant context, further enhancing the diagnostic process. Ultimately, this innovation not only streamlines the workflow but also contributes to improved patient outcomes.

Thermo Scientific Amira Software serves as a robust and versatile solution for visualizing, analyzing, and comprehending life science and biomedical research data across a range of imaging modalities, such as optical and electron microscopy, CT, MRI, and more. Notably efficient and adaptable, Amira Software enhances advanced bioimaging workflows in diverse research domains, including structural biology, cellular biology, tissue imaging, neuroscience, preclinical studies, and bioengineering. Among its standout features are capabilities for importing and processing image data, visualization and exploration, sophisticated segmentation, measurement, quantification, and analysis, as well as tailored tools for molecular visualization, object tracking, filament tracing, meshing for finite element analysis, diffusion tensor imaging, 3D registration, and the analysis of biomaterial deformation. Additionally, Amira Software provides options for customization and integrates seamlessly with ecosystems like MATLAB, Python, and custom C++, making it a highly adaptable tool for researchers. This flexibility ensures that researchers can tailor their workflows to meet specific experimental needs and challenges.

Vesalius3D is an advanced software solution designed for exceptional 3D visualization and exploration of personalized anatomical structures specific to individual patients. This tool enables users to visualize intricate details of patient anatomy that may be overlooked when relying solely on traditional 2D imaging slices. With its user-friendly interface, the software allows for quick navigation within the patient’s anatomy, providing a seamless experience. Importantly, Vesalius3D operates with standard medical imaging modalities like CT, MRI, and Ultrasound, eliminating the need for specialized scans. It includes presets tailored to the most frequently encountered tissue types. Additionally, the software features preconfigured visualizations that let users immediately access results without the hassle of manual adjustments, focusing on commonly used tissues. Beyond visualization, Vesalius3D includes an array of measurement tools, offering both 2D quantification options—such as measuring distances, angles, and contour areas—and 3D quantification capabilities to analyze shapes, contours, and spatial relationships accurately. This comprehensive suite of features empowers healthcare professionals to gain deeper insights into patient anatomy efficiently.

The foundational aspect of our immunotherapy approach lies in our comprehension of antigens and neoantigens, particularly in identifying which variations will be transcribed, translated, processed, and subsequently displayed on the surface of cells via Human leukocyte antigen (HLA) molecules, thus making them recognizable to T cells. We achieve this by employing Gritstone EDGETM, a unique platform powered by machine learning. Creating cancer immunotherapies that incorporate tumor-specific neoantigens proves challenging, mainly because tumors consist of numerous mutations, yet only a fraction of these lead to genuine tumor-specific neoantigens. To tackle this complexity, we have developed EDGE's cutting-edge integrated neural network model, trained with millions of data points gathered from a diverse range of tumor and normal tissue samples across various patient ancestries. This extensive training allows us to enhance the accuracy of neoantigen identification and improve the effectiveness of our immunotherapy strategies.

CryoTrackIMS is a comprehensive software solution tailored for various fields, including molecular biology, cell banking, cellular biology, clinical samples, biorepositories, biobanking, biochemistry, immunology, and protein laboratories, as well as high-throughput screening, quality assurance, IVF labs, and core facilities. Users can effortlessly design any box, plate, or pie layout by choosing from rows and columns or opting for a pie configuration, allowing their custom box to be generated in mere seconds for data input. Efficient inventory management of precious biological samples and specimens is essential for both fundamental research and the biotech industry. Managing extensive collections of diverse samples such as DNA, RNA, plasmids, clones, proteins, peptides, probes, antibodies, enzymes, specimens, tissues, and cell lines can often become a challenging and overwhelming endeavor that results in significant financial costs alongside frustration and wasted time. CryoTrack provides an all-encompassing solution specifically designed for laboratories within universities, clinics, biotechnology firms, and pharmaceutical organizations. This advanced software not only simplifies sample tracking but also significantly enhances lab efficiency and productivity. By streamlining the organization of critical biological materials, CryoTrackIMS empowers researchers to focus more on their experiments and less on administrative burdens.

CADU, a cloud-enabled AI solution created by Odin Vision, is designed to aid in identifying and characterizing dysplasia in individuals with Barrett’s oesophagus during gastroscopy. The system evaluates areas that visually resemble Barrett’s oesophagus and offers insights to help clinicians determine whether the tissue is dysplastic or non-dysplastic. By improving the decision-making process for endoscopists and expediting the examination of the oesophagus, CADU proves to be both time-efficient and cost-effective. Additionally, it functions on a platform that is vendor-neutral, facilitating its use with various endoscopic equipment. The system is CE marked and holds UKCA approval; however, it is not available for commercial sale in the United States. CADU has been adopted in clinical environments, including University College London Hospitals, aiming to enhance the detection of early oesophageal cancer, which can often be difficult to identify due to the subtle nature of initial lesions. Its implementation represents a significant advancement in the early diagnosis of this serious condition, highlighting the importance of technology in modern medicine.

Agri-Labs Information Systems (ALIS) effectively oversees all varieties of raw laboratory data throughout the entire sample life cycle. Designed specifically for Microsoft's 32-bit operating systems, our informatics solution transcends the limitations of standard Excel spreadsheets that merely serve as front-ends to Access databases. Furthermore, ALIS LIMS is developed in a contemporary programming language, steering clear of obsolete technologies. It is comprised of a sophisticated inter-relational database featuring six modules—Soil, Water, Plant Tissue, Manure/Compost, Feeds/Forage, and Air—that are grounded in the principles of the Earth's hydrologic cycle, all while employing the reliable and enduring Clarion 5.5 language, which is particularly well-suited for agricultural and natural resource laboratories. Additionally, ALIS LIMS can effortlessly handle a growing volume of samples, demonstrating its scalability and efficiency. We have also prioritized keeping ALIS budget-friendly for our users.

Harness the power of Artificial Intelligence to streamline your workflow in the orthodontic practice, ensuring efficiency and speed that are essential. Utilize AI for obtaining measurements that assist in crafting treatment plans, projecting skull growth, predicting treatment outcomes, and running simulations. This technology allows for the rapid placement of cephalometric landmarks, significantly reducing the time spent on these tasks. Organize all related documents into a timeline format, making them easily accessible whenever needed. Be prepared to present and discuss the advancements in orthodontic treatment with your patients at any moment. Our cephalometric software is offered in two distinct editions, each featuring unique tools; however, they share the same advanced cephalometric engine, guaranteeing quick and accurate results. The user-friendly AudaxCeph SuperEasy, enhanced with AI, takes on the task of automatically placing cephalometric points on both soft and hard tissue landmarks in just seconds, transforming the efficiency of your practice. With this innovative approach, you can focus more on patient care and less on administrative tasks.

Transform your administrative tasks into a seamless and efficient process with EquiPro Connect. Our innovative software equips you with essential tools to maintain organization, save valuable time, and alleviate stress regarding your everyday operations. EquiPro Connect is specifically tailored for equine professionals, including massage therapists, chiropractors, physiotherapists, PEMF practitioners, saddle fitters, and farriers. With our user-friendly application, you can manage all aspects of your business directly from your mobile device, establishing a new benchmark in the industry. The platform integrates CRM functionality, scheduling, billing, record management, detailed session reporting (covering skeletal, muscular, and soft tissue), and marketing, allowing you to dedicate more time to your passion. Managing your business has never been this straightforward, setting you on the path to success. Moreover, you’ll find that our comprehensive tools empower you to focus on delivering exceptional care to your clients and their horses.

Agri-Data® Advanced is tailored for entities requiring comprehensive data management across various farms. This innovative solution is utilized by agricultural retailers, food processing companies, land management organizations, large-scale corporate farms, insurance firms, and product manufacturers, all of which leverage its capabilities. Agricultural retailers enhance their service offerings by securely storing critical field and farm information, which encompasses field applications and scouting reports. Additionally, the platform streamlines efficiency through automated reporting of soil, tissue, and manure lab results. On the other hand, food and ingredient processors reap the benefits of centralized data management, allowing managers and staff to easily share and analyze information, engage in grower cost benchmarking, manage raw procurement contracts, and document sustainability efforts along with stewardship programs. Overall, Agri-Data Advanced significantly improves operational efficiency for a diverse range of agricultural stakeholders, fostering better decision-making and resource management.

Facilitate cross-chain and cross-product payments seamlessly with your chosen wallet, custodian, exchange, or transfer network while minimizing “fat-finger” mistakes and removing Herstatt risk through advanced subatomic smart settlement technology. Organize your transaction management effectively and eliminate spreadsheet disarray by handling the initiation, tracking, and closure of your derivatives and loans in a unified platform. Our software serves as a vital link between your wallet and custody networks and your execution venues, enhancing the accessibility of your off-exchange capital while reducing your costs associated with trade funding and liquidity. Optimize your post-trade transfers with our innovative settlement engine, which acts as a crucial connector between execution and custody, potentially decreasing your on-chain transactions by up to 99%. Additionally, streamline transaction resolution across all parties and execution locations with our support for cross-chain operations and custodian-agnostic integration capabilities, ensuring a holistic approach to financial transactions. This comprehensive solution not only enhances efficiency but also empowers users to maintain better control over their financial operations.

PAT Horticulture software is a standard business management program, specifically designed for horticulture. PAT helps growers, traders, and producers of ornamentals, vegetables, and trees to manage their business and improve their organization. PAT can be easily and flexiblely set up to suit your business' needs. The PAT CORE SYSTEM integrates all business processes into one application. It is the central component that connects all modules: Master Data Management. Secure User Rights System. Configurable Permission System. Business Process Integration. Modules that determine the available amounts in real time Production/stock vs. Sales, Real-time Monitoring, Customizable Calcul Keys, Prognosis for Secondary Products.

Choose two tailored cell groups by utilizing metadata to uncover their most significantly differentially expressed genes. Utilize the extensive collection of millions of cells from the integrated CZ CELLxGENE corpus for in-depth analysis. Conduct interactive examinations of datasets to investigate how gene expression patterns are influenced by spatial, environmental, and genetic variables through an intuitive no-code user interface. Gain insights into existing datasets or leverage them as a foundation to discover new cell subtypes and states. Census offers the capability to access any customized segment of standardized cell data available within CZ CELLxGENE, with opportunities for exploration in both R and Python. Delve into an interactive encyclopedia containing over 700 cell types that includes comprehensive definitions, marker genes, lineage information, and associated datasets all in one location. Additionally, you can browse and obtain hundreds of standardized data collections along with more than 1,000 datasets that detail the functionality of both healthy mouse and human tissues, enriching your research and understanding of cellular biology. This resource provides a valuable tool for researchers aiming to enhance their exploration of cellular dynamics and gene expression.

After more than twenty years of continuous enhancement, PAM has evolved through invaluable insights and recommendations from a multitude of clients with varying requirements, ensuring it remains at the forefront of agricultural technology. This innovative tool consistently grows in strength and utility, allowing users to Budget, Plan, and Record their agricultural activities effectively for crop establishment and monitoring. Users have the option to integrate PAM with either a Mapping Module or a Precision Farming Mapping Module, significantly boosting the software's reporting functions and enriching the overall experience of production tracking. By meticulously monitoring all expenses and revenues, users can leverage robust gross margin reports to identify which areas of production are facing challenges and which ones are thriving. Additionally, PAM allows for in-depth analysis of water usage efficiency, providing comprehensive rainfall and weather graphs, along with comparative reports on different varieties and blocks, to offer a clear insight into operational performance. Furthermore, the software facilitates data imports from soil and tissue testing labs, enabling users to graph results or visualize data directly on their farm maps, making it an indispensable tool for modern farming. This holistic approach to farm management ensures that every aspect of agricultural activities is optimized for success.

Brainlab's Elements Multiple Brain Metastases SRS represents a cutting-edge software solution aimed at optimizing the planning and execution of treatment for patients suffering from multiple brain metastases. This innovative workflow allows healthcare providers to target several metastases at once without subjecting the entire brain to radiation, thus significantly shortening the duration of treatment delivery. The procedure starts with pre-planning steps that are supported by automation, which includes tasks like image fusion, distortion correction, object outlining, and segmentation; all of which enhance both the speed and precision of the planning process. The software utilizes inverse-optimized dynamic conformal arc techniques, focusing on a single isocenter to achieve highly conformal dose distributions with sharp gradients, ensuring accurate target coverage while protecting surrounding healthy tissue. This method facilitates the rapid generation of consistent, high-quality radiosurgery plans within minutes, ultimately benefiting clinicians and patients alike by reducing treatment durations and enhancing overall outcomes. Moreover, the efficiency and effectiveness of this software can lead to improved patient satisfaction and a more streamlined clinical workflow.

Riverain Technologies has developed ClearRead Xray, a suite of five applications that have received FDA clearance, aimed at improving the speed and precision of interpreting chest X-rays within healthcare settings, all without the need for extra equipment, procedures, or exposure to radiation. This innovative platform utilizes specialized suppression technology to create a clear view of the chest, which significantly aids in the swift and precise identification of cardiothoracic conditions. Among its standout features are the generation of bone-suppressed images that enhance visualization, the ability to spot potential lung cancer nodules, a decrease in the time required to read portable X-rays, automatic comparisons with previous examinations to emphasize changes, and compatibility across various imaging devices and protocols throughout the enterprise. Additionally, the ClearRead Xray Bone Suppress feature notably enhances soft tissue visibility by minimizing the presence of bone structures in digital images, thereby assisting radiologists in uncovering nodules that may have previously gone unnoticed. This comprehensive approach not only boosts diagnostic capabilities but also streamlines workflow in busy medical environments.

Cosmas seamlessly integrates patients, healthcare providers, hospitals, and manufacturers into a unified, patient-focused platform designed for tissue, cell, and gene therapies. It facilitates the digital management of sophisticated therapies along with the intricate supply chain associated with human materials. The system is adaptable and can accommodate the varying requirements of both large and small healthcare centers. From the initial phases of clinical trials to the final stages of commercialization, Cosmas ensures comprehensive traceability and efficient management of treatments throughout the entire supply chain. It effectively oversees the chain of identity and custody, providing real-time product tracking through a complex value chain, which guarantees safety and efficacy in treatment delivery. A wide range of interfaces with third-party software and laboratory equipment is readily available, enhancing its usability. As a frontrunner in digital solutions for orchestrating advanced therapies, Cosmas empowers biotech and pharmaceutical companies to deliver precise dosages to patients, while also optimizing and scaling the digital landscape for personalized therapies, ultimately transforming patient care. This innovative platform stands poised to redefine how therapies are managed and delivered in the healthcare sector.

Brainlab's Elements Spine Stereotactic Radiosurgery (SRS) represents a cutting-edge software solution aimed at refining the management of spinal metastases. This innovative workflow features automation at each phase, encompassing anatomical mapping, curvature adjustments, and target identification, which guarantees precision and uniformity down to submillimetric levels. A distinctive algorithm addresses variations in spinal curvature, thereby improving the accuracy of image fusion. The software employs automatic segmentation of spinal anatomy through a patented synthetic tissue model that effectively identifies and labels different spine levels for accurate dose calculations. Tools for outlining spinal tumors are included for Gross Tumor Volume (GTV) contouring, along with automatic suggestions for the Clinical Target Volume (CTV) and a cropped spinal canal object in alignment with International Spine Consortium Guidelines. Furthermore, the integration of AI-driven contouring solutions allows for the swift and dependable delineation of over 200 structures, including lymph nodes. This advancement not only streamlines the treatment process but also enhances overall patient outcomes in spinal cancer management.

Efficiently create and oversee a variety of Employee Resource Groups (ERGs) and their sub-groups, including managing memberships, organizing events, maintaining calendars, sending notifications, and providing resources, all in real time. Enhance engagement and track progress as it happens, with Manage ERG serving as your comprehensive dashboard for overseeing structures, councils, planning, budgets, schedules, and reports—available in ten languages and through various user permissions. Foster a sense of community among members while facilitating easy referrals for hires specific to each ERG. Experience significant time and resource savings across all ERG management tasks, allowing Diversity and Inclusion (D&I) administrators to prioritize member engagement and program development instead of dealing with scattered and inefficient technologies. This tool is an exceptional asset for fulfilling your workplace diversity and inclusion objectives, providing a complete approach to ERG management that emphasizes planning, execution, transparency, and accountability. As events act as the fundamental link in promoting diversity and inclusion, ensuring their sustainability is crucial, especially in an era where social distancing has become the norm. It’s vital to adapt strategies that ensure the continuity and impact of these initiatives.

Silhouette® offers a comprehensive range of tools for imaging, three-dimensional measurement (including both depth and volume), and the documentation of soft tissue and skin lesions such as wounds. It is FDA cleared, adheres to HIPAA regulations, and includes integration capabilities with electronic medical records. Among its advantages, the system is tailored for both clinical trials and everyday clinical use, featuring a variety of devices designed to accommodate diverse user requirements throughout the continuum of care. Users can choose from both wired and wireless 3D imaging devices, as well as applications for mobile devices, ensuring that each site and user can find the right fit for their needs. This innovative solution facilitates the capture of images, depth measurements, data analysis, and reporting within a single, user-friendly, and secure platform. The centralized database, known as SilhouetteCentral, allows multidisciplinary care teams and risk managers to access and analyze captured data instantly and securely from various locations. By delivering exceptional precision and consistency in data collection, Silhouette® significantly mitigates risks associated with inaccuracies in medical documentation and enhances the overall quality of care. In this way, it ensures that healthcare professionals can rely on accurate data to inform their treatment decisions.

SignalPET 360° serves as a comprehensive veterinary radiology solution that fuses cutting-edge vision-based artificial intelligence, context-sensitive language processing, and PACS technology, while also providing continuous access to board-certified radiologists for quick and actionable imaging insights across various modalities, including X-rays. This platform systematically evaluates every case and image, functioning as an additional layer of analysis to deliver instant AI-derived insights in just minutes, with a keen focus on essential pathologies in areas such as thoracic, abdominal, musculoskeletal, soft tissue, and dental regions, and it generates structured preliminary evaluations in less than five minutes. Its Complete Report harnesses advanced machine vision and extensive language models to generate in-depth findings, conclusions, and clinical recommendations that closely resemble a conventional radiologist's report, typically within a 30-minute timeframe, thereby aiding clinicians in comprehending the observations, their implications, and potential subsequent actions. In addition, this innovative platform significantly enhances the efficiency and accuracy of veterinary diagnostics, ultimately improving patient care and outcomes.

ChameleonDR seamlessly integrates with your existing film or CR x-ray system, allowing for straightforward installation over current components. Once in place, it delivers high-definition image quality while significantly reducing radiation exposure by up to 300%, depending on the specific procedure performed. This remarkable performance is achieved through cutting-edge acquisition technologies embedded in a superior HD detector panel, paired with sophisticated image processing capabilities. The A3 image post-processing technology automatically applies a series of advanced algorithms that consider factors such as patient size and density, working together seamlessly like a finely-tuned equalizer enhances the sound of a premium audio setup. As a result, clinicians can expect the highest caliber of imaging, with optimal bone-to-tissue contrast. Radiology technicians will be amazed by the clarity and detail of the images displayed on their new 4K ultra HD touch screen workstations. The difference made by a 15MP image, expertly calibrated, is invaluable for ensuring accurate and confident diagnoses. Furthermore, this innovative system not only enhances image quality but also streamlines workflow efficiency in clinical settings.

Create a customized eCommerce technology stack that caters specifically to your brand's current and future requirements. Nacelle acts as the essential link that integrates data from various systems, enabling brands to craft an ideal commerce tech framework. By utilizing real-time commerce data streams, you can avoid outdated information, which is crucial for a seamless shopping experience. With sub-second page load times, your conversion rates and average order value (AOV) will see significant improvement. This approach minimizes interdependencies within your team and empowers your developers to work more efficiently. Exceeding customer expectations across all devices is achievable with a single codebase. Additionally, Nacelle's hosted backend solution reduces the complexities associated with DevOps, making it easier for brands to operate. You have the option to invest in top-tier technology solutions or create your own tailored tools. Having the adaptability to switch out platforms and select the best tools to enhance the customer experience is vital, and Nacelle provides that capability. Designed for merchants aiming to deliver an exceptional online shopping journey, Nacelle ensures you can connect with customers wherever they may be, today and in the future. Embracing this flexibility positions your brand to thrive in an ever-evolving eCommerce landscape.

Harnessing RNA sequencing (RNA-seq) data alongside Artificial Intelligence presents both a crucial necessity and a significant opportunity for creating therapies aimed at correcting splicing errors. By leveraging machine learning, we can uncover novel splicing errors and swiftly formulate therapeutic compounds to address them. Our AI platform, SpliceCore, is specifically designed for discovering RNA therapeutics. This cutting-edge technology focuses on analyzing RNA sequencing data with unparalleled efficiency. It can swiftly identify, evaluate, and validate potential drug targets, outpacing traditional methodologies. Central to SpliceCore is our unique repository containing over 5 million potential RNA splicing errors, making it the largest of its kind globally and instrumental for testing any RNA sequencing dataset submitted for analysis. The integration of scalable cloud computing allows us to handle vast quantities of RNA sequencing data in a way that is not only efficient but also cost-effective, significantly speeding up the pace of therapeutic advancements. This innovative approach promises to revolutionize the landscape of RNA therapeutics.

We combine clinical and experimental data through machine learning techniques to explore human disease biology and promote the development of precision medicine. Our innovative Contingent AI™ technology comprehends the intricate relationships present in the data, yielding advanced insights. To combat data bias, we refine our machine learning models based on decisions made during the pre-processing and feature engineering phases. We utilize zebrafish, cellular, and various phenotypic animal models to test and confirm in silico predictions through in vivo experiments, along with genetic modifications conducted both in vitro and in vivo to enhance translation. By employing active learning and computer vision on validated models that focus on cardiac, central nervous system, and rare disorders, we swiftly integrate new data into our machine learning frameworks, allowing for continuous improvement and adaptation in our methodologies. This iterative process not only enhances the accuracy of our predictions but also enables us to stay at the forefront of research in precision medicine.

Our innovative AI engine is revolutionizing the drug discovery process, enabling the creation of superior medications at an accelerated pace. The breakthroughs we achieve contribute to the development of medicines more efficiently and effectively. Our portfolio of AI-driven discoveries encompasses entirely owned and collaboratively developed pipeline assets, supported by leading investors in the industry. Atomwise has engineered a cutting-edge machine-learning discovery platform that merges the capabilities of convolutional neural networks with extensive chemical libraries to identify new small-molecule treatments. The key to transforming drug discovery through AI lies in our talented team. We are committed to enhancing our AI platform and leveraging it to revolutionize the discovery of small molecule drugs. It is essential that we confront the most daunting and seemingly insurmountable targets, streamlining the entire drug discovery process to provide developers with increased opportunities for success. Enhanced computational efficiency allows us to screen trillions of compounds virtually, significantly boosting the chances of finding viable solutions. Our impressive model accuracy has successfully addressed the persistent issue of false positives, underscoring the reliability of our approach. Ultimately, our dedication to innovation and excellence sets us apart in the quest for breakthrough therapies.

BIOiSIMTM represents a groundbreaking 'virtual drug development engine' that significantly enhances the drug development sector by effectively identifying drug compounds that are most likely to provide meaningful therapeutic benefits for various diseases or conditions. We provide an array of translational solutions that are tailored to meet the specific needs of your pre-clinical and clinical initiatives. Central to our offerings is the highly validated BIOiSIMTM platform, which supports the development of small molecules, large molecules, and viruses. This innovative platform is underpinned by extensive data derived from thousands of compounds across seven different species, resulting in a level of robustness that is uncommon in the field. Emphasizing human health outcomes, the heart of the platform features a translatability engine that seamlessly converts insights gained from different species. Importantly, the BIOiSIMTM platform can be deployed prior to the initiation of preclinical animal trials, facilitating earlier insights and potentially reducing the costs associated with outsourced experimentation. By integrating these advanced capabilities, we aim to streamline the drug development process and accelerate the journey from discovery to market.

The Suite is designed to be both secure and scalable, featuring a contemporary and user-friendly interface that empowers scientists to have full control over the configuration of workflows for various techniques, modalities, and data types. The latest iteration, Signals VitroVivo 3.0, formerly known as Signal’s Screening, effectively converts raw data into practical insights, while Signals Inventa 3.0, previously called Signals Lead Discovery, serves as advanced analytics software that allows researchers to publish results effortlessly from diverse data sources. Additionally, it facilitates the capture of experimental data, oversees materials management, and streamlines collaboration workflows within an easy-to-navigate cloud-based electronic notebook. With adaptable visualizations and the ability to automate instrument data processing, the Suite enhances data quality and ensures reproducibility in research. It also provides a unified data management system for scientific outcomes, enriched with dynamic, interactive analytics. Furthermore, its extensibility allows for seamless integration with internal systems and partner processes, making it an invaluable tool for scientific discovery and innovation.

EVIDENS is an advanced AI platform that facilitates the discovery of digital cohorts, enhances research capabilities, promotes collaboration, and enables the sharing of insights across extensive hospital data sets. With the ability to swiftly annotate and convert your data into AI-compatible formats, users can efficiently filter populations by various clinical outcomes or demographic factors. The platform allows for limitless keyword filtering by training AI models to perform targeted searches. Furthermore, users can explore and establish criteria for cohort identification with the support of intelligent AI tools. Training AI models to automate the analysis process and categorize data into distinct groups can be done quickly and efficiently. The platform outputs AI-ready cohorts to facilitate the testing of clinical hypotheses in research studies. Users can effortlessly monitor the status and tasks related to all their projects and collaborators, while also being able to observe and engage with activities aligned with their research interests. Additionally, collaborative tools are provided to enable simultaneous efforts in creating, training, and validating AI models, fostering a productive research environment. Ultimately, EVIDENS streamlines the entire research process, making it more efficient and effective for all involved.

Genedata Biologics® enhances the development of biotherapeutics, including bispecifics, ADCs, TCRs, CAR-Ts, and AAVs, providing a comprehensive solution for the industry. Recognized as the leading platform in the field, it seamlessly unifies all discovery workflows, allowing researchers to prioritize genuine innovation. By utilizing a pioneering platform that was purposefully created to digitalize the biotherapeutic discovery process, research can be accelerated significantly. The platform simplifies intricate R&D tasks by facilitating the design, tracking, testing, and evaluation of novel biotherapeutic drugs. It is compatible with various formats, such as antibodies, bi- or multi-specifics, ADCs, innovative scaffolds, and therapeutic proteins, as well as engineered therapeutic cell lines like TCRs and CAR-T cells. Functioning as a comprehensive end-to-end data backbone, Genedata Biologics connects all R&D processes, including library design, immunization, selection and panning, molecular biology, screening, protein engineering, expression, purification, and protein analytics, ultimately leading to thorough assessments of candidate developability and manufacturability. This holistic integration ensures that researchers can make informed decisions and push the boundaries of biotherapeutic innovation effectively.